THE EFFECTIVENESS OF THERAPY IMMUNOSTIMULATING ONYCHOMYCOSIS IN ELDERLY AND SENILE AGES

THE EFFECTIVENESS OF THERAPY IMMUNOSTIMULATING ONYCHOMYCOSIS IN ELDERLY AND SENILE AGES

Kasymov O.I., Kasymov A.O.

The department of dermatovenerology of TIPGPMP

The article shows the efficiency of complex method of treatment of mycosis stop with onychomycosis in elderly and senile ages using immunostimulant thymocine 45 patients aged 60 to 85 years. Using methods of bacteriological research, 64.4% of the patients were grown culture of Trichophyton rubrum, in 11.1% of Trichophyton mentagrophytis var.interdigitale, in 24.4% – fungi not sown. Intertriginous form of mycosis stop diagnosed in 12 patients, dishydrotic – 6, mixed – 18. Combination squamous and intertriginous forms was observed in 11 patients, squamous, dishydrotic and intertriginous – for 7. The erased form of mycosis stop was noted in 9 patients. Immediate and remote results of treatment showed a significant advantage of an integrated method of treatment with the application of immune system stimulant. By the end of 6 months of follow-up highly effective results when immunostimulating therapy were achieved in 83,3% of patients in the group of patients treated without immunomodulator, efficiency indicator accounted for 61.9%. Among patients with total-dystrophic and proximal forms of combined treatment of onychomycosis gave clinical and mycological recovery in 66.7%, without immunostimulant – only 50%. The average speed of growth of nail plates stop in complex treatment using thymocine amounted to 1.37±0.06 mm per month, which is much faster than in the treatment only systemic antimycotics. The obtained results have shown the effectiveness of immunostimulating method of treatment of athlete's foot with onychomycosis, compared with the traditional.

REFERENCES

1. Abidova Z.M., Ikramova N.D. Sostoyanie immuniteta u bol'nykh mikozom stop i onikhomikozom [The Condition of immunity in patients with mycosis of the foots and onychomycosis]. Problemy meditsinskoy mikologii, 2006. T.8, no. 2, pp.15.

2. Bakulev A.L. Ob otdalennykh rezul'tatakh effektivnosti terbinafina (lamizila) pri onikhomikozakh, assotsiirovannykh s dermatofitami [About remote result of efficiency Terbinafine (Lamizile) at onychomycosis, associated with dermatophytes] .Klinicheskaya dermatologiya i venerologiya, 2008, no. 4, pp. 64-66

3. Vasenova V.Yu., Butov Yu.S., Panova T.G. Osobennosti klinicheskogo techeniya mikoza i onikhomikoza stop i kistey u patsientov pozhilogo vozrasta [Particularities of the clinical current mycosis and onychomycosis foots and cyst in patient of the elderly age]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney, 2004, no. 2, pp.34-36

4. Vasenova V.Ju., Butov Ju.S., Shkol'nikov M.M. [Principles therapy of onychomycosis]. Tezisy dokladov II sezda mikologov Rossii [Thesises report II congress mycologies of Russia]. 2008, pp. 420-421.

5. Egorenkova N.P., Klyueva T.A. O lechenii onikhomikoza stop u bol'nykh s tyazheloy somaticheskoy patologiey [About treatment onychomycosis foots patients with heavy somatic pathology]. Vestnik dermatologii i venerologii, 2007, no. 2. pp. 46-47.

6. Lyashko A.K. Vegetativnye i sosudistye narusheniya pri onikhomikozakh i metody ikh kompleksnoy terapii. Avtoref. diss. kand. med. nauk [Autonomy and vascular breaches at onychomycosis and methods their complex therapy. Kn. med. sci. diss.]. St. Peterburg, 2006. 16 p.

7. Nikolaeva L.A., Rudaeva L.M., Kasymov A.O. Sovershenstvovanie terapii bol'nykh psoriazom [Improvement therapy patients with psoriasis]. Materialy godichnoy nauchno-prakticheckoy konferentsii TGMU [Material annual scientifically-practical conference TSMU]. Dushanbe, 2009, pp. 157-158.

8. Novikova L.A., Bahmet'eva T.M. Nekotorye epidemiologicheskie osobennosti dermatomikozov [Some epydemiological particularities dermatomycosis]. Problemy meditsinskoy mikologii, 2008, T. 10, no. 2, pp. 68

9. Novikov A.I., Novikov Yu.A., Chesnokova M.G., Markelova M.V. Osobennosti diagnostiki i kliniki onikhomikoza stop [Particularities of the diagnostics and clinics onychomycosis foots]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney, 2008, no. 5, pp. 66-70

10. Samcov A.V. Osobennosti lecheniya onikhomikozov u pozhilykh lyudey [Particularities of the treatment onychomycosis in elderly people]. Vestnik dermatologii i venerologii, 2004, no. 2. pp.60-62

11. Sergeev A.Yu. Gribkovye zabolevaniya nogtey [Fungous diseases of nails]. Moscow, Natsional'naya akademiya mikologii Publ., 2007. 164 p.

12. Sino I.S., Mukhiddinova G.M., Zoirova N.P. [Using thymocinum at treatment vitiligo]. Materialy godichnoy nauchno-prakticheckoy konferentsii TGMU [Materials of annual scientifically-practical conference TSMU]. Dushanbe, 2009, pp. 181-182.

13. Tadzhibaev U.A. Effektivnost' timotsina v kompleksnom lechenii urogenital'nogo khlamidioza u muzhchin [Efficiency of thymocinum in complex treatment urogenilal chlamydios in man’s]. Zdravoohranenie Tadzhikistana. Dushanbe, 2011, no. 3, pp.69-74

14. Faergemann J., Baran R. Epidemiology, clinical presentation and diagnosis of onychomy­cosis. // Br. J. Dermatol. 2004. Vol. 149, Suppl.65. P. 1-4

15. Gupta A.K. Assessing the efficacy of the oral antifungal agents in the management of dermatophyte toenail onychomycosis. PS 94 Venerology JEADV. 2004, Vol.18, Suppl.I. pp.58-59

16. Hamauda T., Jeffries S.D., Ekiadios E.M. et al. Class-specific antibody in human dermatophytosis reactive with Trychophyton rubrum derived antigen. Mycopathologia. 1994, Vol.127, no. 2. pp.83-88

17. Tosti A., Hay R., Arenas-Guzman R. Pa­tients at risk of onychomycosis-risk factor identifi­cation and active prevention. J.Eur Acad Dermatol Venerol. 2005, Vol. 19, Supple 1. pp. 13-6

Information about the authors:

Kasimov Abos Olimovich – the postgraduate of department of dermatovenereology TIPGPMP; Tel: (992) 918523285; e-mail: a.kasymov@ hotmail.com

Comments

Back to Top